Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg
TED · 304490-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€2,901,898 · 2,901,898.04 EUR
WinnerFRESENIUS KABI ESPAÑA, S.A. | BIOCON BIOLOGICS SPAIN, S.L. | JANSSEN CILAG, S.A. | SANDOZ FARMACEUTICA S.A.
Who already wins at this buyer
Firms with recorded awards from Servicio Murciano de Salud - Junta de Compras in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| TAKEDA FARMACÉUTICA ESPAÑA, S.A. | PFIZER, S.L. | SWEDISH ORPHAN BIOVITRUM, S.L. (SOBI) | BAYER HISPANIA, S.L. | NOVO NORDISK PHARMA, S.A. | 1 | €9,441,858 | 2026-07-20 |
| SANOFI AVENTIS, S.A. | 1 | €2,800,000 | 2026-07-13 |
| AMGEN, S.A. | ROCHE FARMA, S.A. | PFIZER, S.L. | 1 | €2,509,350 | 2026-07-27 |
| LABORATORIOS URGO, S.L. | SMITH & NEPHEW, S.A. | MOLNYLYCKE HEALTH CARE, S.L. | CONVATEC, S.L. | 1 | €2,154,040 | 2026-05-08 |
| GLAXOSMITHKLINE, S.A. | 1 | €1,320,000 | 2026-06-30 |
Full buyer profile: what Servicio Murciano de Salud - Junta de Compras buys and who wins it →
CPV codes
33652300 Medical equipment & pharmaceuticalsDescription
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg para los Centros dependientes del Servicio Murciano de Salud
Similar tenders
Closest by meaning — across languages, via embeddings.